Kenneth Custer, executive vice president and president, Lilly Cardiometabolic Health, said: “The SURPASS-CVOT results show that Mounjaro preserved the cardioprotective benefit of Trulicity, a GLP-1 ...

In this retrospective study, patients who started a GLP-1 agonist experienced significant declines in hidradenitis ...